The results show that the high expression of PLC-β1 in cells can stimulate the phosphorylation of ERK1/2 pathway, while ERK inhibitor can inhibit the promotion effect of PLC-β1 on the growth of hepatocellular carcinoma cells. Here, PLCB1 is linked to hepatocellular carcinoma.